Cargando…
We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?
Autores principales: | Bloom, Patricia P., Pasricha, Trisha S., Viveiros, Kathleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229745/ https://www.ncbi.nlm.nih.gov/pubmed/32425706 http://dx.doi.org/10.1016/j.cgh.2020.05.018 |
Ejemplares similares
-
Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management
por: Bloom, Patricia P., et al.
Publicado: (2020) -
CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016) -
COVID-19 induced psychosis. Should we be concerned?
por: Costa, P., et al.
Publicado: (2022) -
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020) -
Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
por: Shahgolzari, Mehdi, et al.
Publicado: (2021)